Ansing, Aglenn E.
HRN: 21-64-46 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CEFUROXIME 1.5GM (VIAL)
07/23/2022
07/30/2022
IV
1.5g
Q8
CAP-MR
Waiting Final Action
07/24/2022
CEFTRIAXONE 1G (VIAL)
07/24/2022
07/30/2022
IV
2g
OD
CAP-MR
Waiting Final Action